glp-1 dementia Time to with GLP‐1 RAs versus placebo in pooled RCTs. In the GLP-1 Microdosing, Brain Health &

Specifically, 2,539 ICSRs (37.6%) were associated with exenatide, 1981 (29.3%) with liraglutide, and 1,352 (20.0%) with dulaglutide

Skin lightening IV therapy with glutathione reduces melanin production, tipping the balance in favor of pheomelanin, resulting in a brighter, more radiant complexion

For most people, most of the weight lost is fat

Full 2026 regulatory status, Category 2 reclassification updates, compounding regulations, and published research

Numerous studies have demonstrated that intestinal epithelial cells are more vulnerable to ferroptosis in a low-density environment

Zn-DHM nanozymes regulate metabolic and immune homeostasis for early diabetic wound therapy